Cargando…
COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis
OBJECTIVES: Mass vaccination campaigns can rapidly increase the vaccination rate for the COVID-19 vaccine, the establishment of mass vaccination centers is indispensable. At the beginning of March 2021, China began to carry out COVID-19 vaccination activities nationwide. Here, we aimed to evaluate t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313396/ https://www.ncbi.nlm.nih.gov/pubmed/37397712 http://dx.doi.org/10.3389/fpubh.2023.1072883 |
_version_ | 1785067118529609728 |
---|---|
author | Fan, Jie Zhu, Ling Wu, Xiaohua Luo, Chunyu Huang, Ailong Wang, Wei |
author_facet | Fan, Jie Zhu, Ling Wu, Xiaohua Luo, Chunyu Huang, Ailong Wang, Wei |
author_sort | Fan, Jie |
collection | PubMed |
description | OBJECTIVES: Mass vaccination campaigns can rapidly increase the vaccination rate for the COVID-19 vaccine, the establishment of mass vaccination centers is indispensable. At the beginning of March 2021, China began to carry out COVID-19 vaccination activities nationwide. Here, we aimed to evaluate the criteria established by mass vaccination centers, COVID-19 vaccination experience, the incidence of adverse events following immunization and opinions. METHODS: We describe the layout and functioning of Nan’an District mass vaccination center, the working mechanism, experience and effectiveness. Distribution of COVID-19 vaccine vaccination and adverse events following immunization reported in the mass vaccination center of Nan’an District were evaluated. RESULTS: From March 26, 2021 to April 28, 2022, the mass vaccination center has inoculated about 381,364 doses of COVID-19 vaccine to the population. The study found that the incidence of adverse events following immunization (AEFI) was very low (1.04/100000). The chances of having AEFI were significantly higher in COVID-19 vaccine (CHO cell) than COVID-19 vaccine (Vero cell). CONCLUSION: The mass vaccination center was running successfully. It was effective and safe, providing vaccination services and increasing COVID-19 vaccination rates among the population. The experience of the mass vaccination center for COVID-19 in China can provide a reference for other countries and regions to carry out COVID-19 vaccination. |
format | Online Article Text |
id | pubmed-10313396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103133962023-07-01 COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis Fan, Jie Zhu, Ling Wu, Xiaohua Luo, Chunyu Huang, Ailong Wang, Wei Front Public Health Public Health OBJECTIVES: Mass vaccination campaigns can rapidly increase the vaccination rate for the COVID-19 vaccine, the establishment of mass vaccination centers is indispensable. At the beginning of March 2021, China began to carry out COVID-19 vaccination activities nationwide. Here, we aimed to evaluate the criteria established by mass vaccination centers, COVID-19 vaccination experience, the incidence of adverse events following immunization and opinions. METHODS: We describe the layout and functioning of Nan’an District mass vaccination center, the working mechanism, experience and effectiveness. Distribution of COVID-19 vaccine vaccination and adverse events following immunization reported in the mass vaccination center of Nan’an District were evaluated. RESULTS: From March 26, 2021 to April 28, 2022, the mass vaccination center has inoculated about 381,364 doses of COVID-19 vaccine to the population. The study found that the incidence of adverse events following immunization (AEFI) was very low (1.04/100000). The chances of having AEFI were significantly higher in COVID-19 vaccine (CHO cell) than COVID-19 vaccine (Vero cell). CONCLUSION: The mass vaccination center was running successfully. It was effective and safe, providing vaccination services and increasing COVID-19 vaccination rates among the population. The experience of the mass vaccination center for COVID-19 in China can provide a reference for other countries and regions to carry out COVID-19 vaccination. Frontiers Media S.A. 2023-06-15 /pmc/articles/PMC10313396/ /pubmed/37397712 http://dx.doi.org/10.3389/fpubh.2023.1072883 Text en Copyright © 2023 Fan, Zhu, Wu, Luo, Huang and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Fan, Jie Zhu, Ling Wu, Xiaohua Luo, Chunyu Huang, Ailong Wang, Wei COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis |
title | COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis |
title_full | COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis |
title_fullStr | COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis |
title_full_unstemmed | COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis |
title_short | COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis |
title_sort | covid-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313396/ https://www.ncbi.nlm.nih.gov/pubmed/37397712 http://dx.doi.org/10.3389/fpubh.2023.1072883 |
work_keys_str_mv | AT fanjie covid19vaccinationinthemassvaccinationcenterclinicalpracticeandeffectivenessanalysis AT zhuling covid19vaccinationinthemassvaccinationcenterclinicalpracticeandeffectivenessanalysis AT wuxiaohua covid19vaccinationinthemassvaccinationcenterclinicalpracticeandeffectivenessanalysis AT luochunyu covid19vaccinationinthemassvaccinationcenterclinicalpracticeandeffectivenessanalysis AT huangailong covid19vaccinationinthemassvaccinationcenterclinicalpracticeandeffectivenessanalysis AT wangwei covid19vaccinationinthemassvaccinationcenterclinicalpracticeandeffectivenessanalysis |